Lisdexamfetamine Dimesylate Capsule — FDA Drug Shortage
The FDA lists a drug shortage record for Lisdexamfetamine Dimesylate Capsule (capsule) from Hikma Pharmaceuticals USA, Inc. with status Current. The shortage was first posted on 07/14/2023. Reported reason: Shortage of an active ingredient
Shortage Details
- Status
- Current
- Company
- Hikma Pharmaceuticals USA, Inc.
- Package NDC
- 0054-0374-25
- Dosage Form
- Capsule
- Presentation
- Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 0054-0374-25)
- Initial Posting
- 07/14/2023
- Revised Date
Reason
Shortage of an active ingredient